Management of menopause in primary health care;Abordagem da menopausa: Nos cuidados de saúde primários

Acta Medica Portuguesa

Volumn 23, Issue 2, 2010, Pages 227-236

  Cavadas, Luís Filipe ^a   Nunes, Ana ^a   Pinheiro, Marisa ^a   Silva, Pedro Tiago ^b  

^a Serviço de Medicina Geral e Familiar   (Portugal)

^b HOSPITAL PEDRO HISPANO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AVADENE; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; DERMESTRIL SEPTEM; DIENOGEST PLUS ESTRADIOL VALERATE; DROSPIRENONE PLUS ESTRADIOL; DYDROGESTERONE; DYDROGESTERONE PLUS ESTRADIOL; ESTEVA; ESTRADERM MX; ESTRADIOL; ESTRADIOL PLUS NORETHISTERONE ACETATE; ESTRADIOL VALERATE PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL VALERATE PLUS NORGESTREL; ESTRADOT; ESTRIOL; ESTROFEM; ESTRONAR; FEMSETE; FEMSETE COMBI; FEMSETE EVO; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MESTEROLONE; NOMEGESTROL ACETATE; NORETHISTERONE ACETATE; PAUSIGIN; PROGESTERONE; PROMEGESTONE; PROMESTRIENE; TESTIM GEL; TESTOPATCH; TESTOSTERONE; TIBOLONE; TRISEQUENS; UNCLASSIFIED DRUG; VAGIFEN;

AGING; CLIMACTERIUM; FOLLOW UP; GENERAL PRACTITIONER; HEALTH PROMOTION; HORMONE SUBSTITUTION; HUMAN; LIFE EXPECTANCY; MEDLINE; MENOPAUSE; MORTALITY; POSTMENOPAUSE; PRIMARY HEALTH CARE; QUALITY OF LIFE; REVIEW; URINE INCONTINENCE; VAGINA ATROPHY; VAGINA BLEEDING;

FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; PRIMARY HEALTH CARE;

EID: 77953412342     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Society of Obstetricians and Gynaecologists of Canada: Canadian Consensus Conference on Menopause, 2006 Update. J Obstet Gynaecol Can 2006;28(2 Supl 1):S7-S94
2. Society of Obstetricians and Gynaecologists of Canada: Canadian Consensus Conference on Menopause, 2009 Update. J Obstet Gynaecol Can 2009;S1-S48
3. NOVAIS C, BERNARDO C, MARQUES I: Terapêutica hormonal de substituição - qual a evidência. Patient Care. 2008;11:65-9
4. BECKMANN CR, LING FW, LAUBE DW, SMITH RP, BARZANSKY BM, HERBERT WN: Menopause. Em: Obstetrics and Gynecology, Fifth Edition. USA: Lippincott Williams & Wilkins 2005;p.482-493
5. Sociedade Portuguesa de Ginecologia e Sociedade Portuguesa de Menopausa: Consenso e Estratégias Para a Saúde da Mulher na Pós-Menopausa 2004. S.P.O.G. 2004;1-80
6. ROURA LC: Patologia del climaterio. Em: Sociedad Espanola de Ginecologia y Obstetrícia. Tratado de Ginecologia, Obstetricia y Medicina de la reproducción. Primeira edição. Espanha 2003;p.1374-7
7. UMLAND EM: Treatment Strategies for Reducing the Burden of Menopause-Associated Vasomotor Symptoms. J Manag Care Pharm 2008;14(3):14-19
8. North American Menopause Society: Treatment of menopauseassociated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004;11(1):11-33
9. SUCKLING J, LETHABY A, KENNEDY R: Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006;(4):CD001500
10. SOMBOONPORN W, DAVIS S, SEIF MW, BELL R: Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005;19(4):CD004509
11. International Menopause Society. IMS Updated Recommendations on postmenopausal hormone therapy. Climacteric. 2007;10(3):181-194
12. North American Menopause Society: Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008;15(4):584-603
13. CANDELAS R: Problemas de la menopausia. Em: Semfyc ediciones. Guía de Actuación en Atención Primaria. Tercera Edición. Barcelona 2006;p.603-612
14. CANONICO M, PLU-BUREAU G, LOWE G, SCARABIN PY: Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008;336:1227-31